Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1
Closed -$7 3268
2022
Q4
$7 Sell
1
-80
-99% -$1.4K ﹤0.01% 3774
2022
Q3
$2K Buy
81
+78
+2,600% +$2.17K ﹤0.01% 3689
2022
Q2
$0 Buy
+3
New +$103 ﹤0.01% 3884
2021
Q2
Sell
-1,283
Closed -$101K 4437
2021
Q1
$101K Sell
1,283
-743
-37% -$48.2K ﹤0.01% 4194
2020
Q4
$117K Buy
+2,026
New +$95.4K ﹤0.01% 4169
2019
Q4
Sell
-1,438
Closed -$42K 4138
2019
Q3
$42K Buy
+1,438
New +$42.8K ﹤0.01% 4046
2016
Q4
Sell
-1,969
Closed -$55K 4080
2016
Q3
$55K Sell
1,969
-5,526
-74% -$155K ﹤0.01% 4008
2016
Q2
$186K Buy
7,495
+6,291
+523% +$230K ﹤0.01% 3893
2016
Q1
$45K Buy
+1,204
New +$45.4K ﹤0.01% 3893
2015
Q4
Sell
-1,367
Closed -$84K 4198
2015
Q3
$84K Buy
+1,367
New +$169K ﹤0.01% 4126

Other funds holding AFMD

Credit Suisse's AFMD Position: Q1 2023 in Review

Credit Suisse sold out of Affimed (AFMD) in Q1 2023, closing a stake of 1 share — an estimated $7 sold.

Credit Suisse first reported a position in AFMD in Q3 2015 and held it in 10 quarters. The position peaked at $186K in Q2 2016. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

  • Credit Suisse reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 1 Affimed share in Q1 2023, an estimated $7.
  • Credit Suisse first reported a position in Affimed in Q3 2015 and held it in 10 quarters.
  • Credit Suisse's Affimed position peaked at $186K in Q2 2016.
  • 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.